336
Participants
Start Date
February 1, 2025
Primary Completion Date
August 31, 2026
Study Completion Date
August 31, 2027
Oral Branched chain Amino acid
The active drug BCAA supplement will be dispensed in a dose of 15 gm once daily x 12 weeks
Rifaximin 550 MG
Active drug rifaximin will be dispensed in a dose of 550mg twice daily x 12 weeks
Lactulose
Both groups will be treated with will be treated with 30-60 ml lactulose three times a day to ensure passage of 2-3 semisoft stools per day
Placebo for BCAA
A placebo comparator of 15 gm of skimmed milk powder will be used.
Placebo for Rifaximin 550mg
Identical placebo sugar pills will be used as a placebo.
RECRUITING
PGIMER, Chandigarh
Indian Council of Medical Research
OTHER_GOV
Post Graduate Institute of Medical Education and Research, Chandigarh
OTHER